Your browser doesn't support javascript.
loading
The Predictive Performance of a Pneumonia Severity Score in Human Immunodeficiency Virus-negative Children Presenting to Hospital in 7 Low- and Middle-income Countries.
Gallagher, Katherine E; Knoll, Maria D; Prosperi, Chrissy; Baggett, Henry C; Brooks, W Abdullah; Feikin, Daniel R; Hammitt, Laura L; Howie, Stephen R C; Kotloff, Karen L; Levine, Orin S; Madhi, Shabir A; Murdoch, David R; O'Brien, Katherine L; Thea, Donald M; Awori, Juliet O; Baillie, Vicky L; Ebruke, Bernard E; Goswami, Doli; Kamau, Alice; Maloney, Susan A; Moore, David P; Mwananyanda, Lawrence; Olutunde, Emmanuel O; Seidenberg, Phil; Sissoko, Seydou; Sylla, Mamadou; Thamthitiwat, Somsak; Zaman, Khalequ; Scott, J Anthony G.
Affiliation
  • Gallagher KE; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom.
  • Knoll MD; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Prosperi C; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Baggett HC; Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
  • Brooks WA; Global Disease Detection Center, Thailand Ministry of Public Health-US CDC Collaboration, Nonthaburi.
  • Feikin DR; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Hammitt LL; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka and Matlab.
  • Howie SRC; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Kotloff KL; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia.
  • Levine OS; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Madhi SA; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Murdoch DR; Medical Research Council Unit, Basse, The Gambia.
  • O'Brien KL; Department of Paediatrics, University of Auckland, New Zealand.
  • Thea DM; Centre for International Health, University of Otago, Dunedin, New Zealand.
  • Awori JO; Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore.
  • Baillie VL; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Ebruke BE; Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa.
  • Goswami D; Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Kamau A; Department of Pathology, University of Otago, Christchurch, New Zealand.
  • Maloney SA; Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand.
  • Moore DP; Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Mwananyanda L; Department of Global Health, Boston University School of Public Health, Massachusetts.
  • Olutunde EO; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Seidenberg P; Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa.
  • Sissoko S; Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Sylla M; Medical Research Council Unit, Basse, The Gambia.
  • Thamthitiwat S; International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka and Matlab.
  • Zaman K; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
  • Scott JAG; Global Disease Detection Center, Thailand Ministry of Public Health-US CDC Collaboration, Nonthaburi.
Clin Infect Dis ; 70(6): 1050-1057, 2020 03 03.
Article in En | MEDLINE | ID: mdl-31111870
ABSTRACT

BACKGROUND:

In 2015, pneumonia remained the leading cause of mortality in children aged 1-59 months.

METHODS:

Data from 1802 human immunodeficiency virus (HIV)-negative children aged 1-59 months enrolled in the Pneumonia Etiology Research for Child Health (PERCH) study with severe or very severe pneumonia during 2011-2014 were used to build a parsimonious multivariable model predicting mortality using backwards stepwise logistic regression. The PERCH severity score, derived from model coefficients, was validated on a second, temporally discrete dataset of a further 1819 cases and compared to other available scores using the C statistic.

RESULTS:

Predictors of mortality, across 7 low- and middle-income countries, were age <1 year, female sex, ≥3 days of illness prior to presentation to hospital, low weight for height, unresponsiveness, deep breathing, hypoxemia, grunting, and the absence of cough. The model discriminated well between those who died and those who survived (C statistic = 0.84), but the predictive capacity of the PERCH 5-stratum score derived from the coefficients was moderate (C statistic = 0.76). The performance of the Respiratory Index of Severity in Children score was similar (C statistic = 0.76). The number of World Health Organization (WHO) danger signs demonstrated the highest discrimination (C statistic = 0.82; 1.5% died if no danger signs, 10% if 1 danger sign, and 33% if ≥2 danger signs).

CONCLUSIONS:

The PERCH severity score could be used to interpret geographic variations in pneumonia mortality and etiology. The number of WHO danger signs on presentation to hospital could be the most useful of the currently available tools to aid clinical management of pneumonia.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Developing Countries Type of study: Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2020 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Developing Countries Type of study: Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2020 Type: Article Affiliation country: United kingdom